Zhongmin Ma
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$2.7MFederal grants as PI3 awards
1Patents grantedLatest Feb 18, 2014
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 1, 2017 | NIH | SBIR Phase I Novel ClopNPT for the treatment of acute coronary syndrome | $225K | Diapin Therapeutics LLC |
| Sep 25, 2015 | NIH | SBIR Phase I Development of DT-109 as an oral therapeutic for type 2 diabetes | $991K | Diapin Therapeutics LLC |
| Sep 25, 2015 | NIH | SBIR Phase II Development of DT-110 as an oral therapeutic for type 2 diabetes | $1.5M | Diapin Therapeutics LLC |
2 patents as inventor
- US 8653026Diapin Therapeutics LLCFeb 18, 2014
- US Diapin Therapeutics LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#704
Awards as PI#822
Patents#155
Companies
- Diapin Therapeutics LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.